Abstract
The aryl hydrocarbon receptor (AhR) is a signal-regulated transcription factor, which is canonically activated by the direct binding of xenobiotics. In addition, switching cells from adherent to suspension culture also activates the AhR, representing a nonxenobiotic, physiological activation of AhR signaling. Here, we show that the AhR is recruited to target gene enhancers in both ligand [isopropyl-2-(1,3-dithietane-2-ylidene)-2-[N-(4-methylthiazol-2-yl)carbamoyl]acetate (YH439)]-treated and suspension cells, suggesting a common mechanism of target gene induction between these two routes of AhR activation. However, gene expression profiles critically differ between xenobiotic- and suspension-activated AhR signaling. Por and Cldnd1 were regulated predominantly by ligand treatments, whereas, in contrast, ApoER2 and Ganc were regulated predominantly by the suspension condition. Classic xenobiotic-metabolizing AhR targets such as Cyp1a1, Cyp1b1, and Nqo1 were regulated by both ligand and suspension conditions. Temporal expression patterns of AhR target genes were also found to vary, with examples of transient activation, transient repression, or sustained alterations in expression. Furthermore, sequence analysis coupled with chromatin immunoprecipitation assays and reporter gene analysis identified a functional xenobiotic response element (XRE) in the intron 1 of the mouse Tiparp gene, which was also bound by hypoxia-inducible factor-1α during hypoxia and features a concatemer of four XRE cores (GCGTG). Our data suggest that this XRE concatemer site concurrently regulates the expression of both the Tiparp gene and its cis antisense noncoding RNA after ligand- or suspension-induced AhR activation. This work provides novel insights into how AhR signaling drives different transcriptional programs via the ligand versus suspension modes of activation.
Footnotes
↵ The online version of this article (available at http://molpharm.aspetjournals.org) contains supplemental material.
This work was supported by the Australian Research Council and National Health and the Medical Research Council of Australia, the Singapore National Research Foundation and the Singapore Ministry of Education under the Research Centre of Excellence Programme, and the Swedish Research Council, the Swedish Cancer Society, and the European Union (FP 7, SYSTEQ).
Article, publication date, and citation information can be found at http://molpharm.aspetjournals.org.
ABBREVIATIONS:
- AhR
- aryl hydrocarbon receptor
- bHLH
- basic helix-loop-helix
- PAS
- Per-Arnt-Sim homology
- HAH
- halogenated aromatic hydrocarbons
- YH439
- isopropyl-2-(1,3-dithietane-2-ylidene)-2-[N-(4-methylthiazol-2-yl)carbamoyl]acetate
- Hsp90
- heat shock protein 90
- Arnt
- aryl hydrocarbon receptor nuclear translocator
- XRE
- xenobiotic response elements
- TCDD
- 2,3,7,8-tetrachlorodibenzo-p-dioxin
- pML
- major late promotor
- bp
- base pair(s)
- PCR
- polymerase chain reaction
- m
- mouse
- HEK
- human embryonic kidney
- shRNA
- short hairpin RNA
- DMSO
- dimethyl sulfoxide
- qRT
- quantitative real-time
- ChIP
- chromatin Immunoprecipitation
- HIF
- hypoxia-inducible factor
- ncRNA
- noncoding RNA
- kb
- kilobase(s)
- TSS
- transcription start site
- HRE
- hypoxia response element
- PTM
- post-translational modification.
- Received March 22, 2012.
- Accepted August 30, 2012.
- Copyright © 2012 The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|